http://orcid.org/0000-0001-6620-5365
References
- Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581–592.
- Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75:74–84.
- De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study . Lancet Oncol. 2014;15:23–34.
- Aunan JR, Cho WC, Søreide K. The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks. A&D. 2017;8:628–642.
- Bongaarts J. Human population growth and the demographic transition. Philos Trans R Soc Lond, B, Biol Sci. 2009;364:2985–2990.
- Engholm G, Ferlay J, Christensen N, et al. NORDCAN–a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49:725–736.
- Engholm G, Ferlay J, Christensen N, et al. Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http://www.ancr.nu. Accessed on January 20, 2019.
- Danish Health Authority. Danskernes Sundhed - Den Nationale Sundhedsprofil 2017. [Health of the Danes – The National Health Profile 2017]. Danish. URL: https://www.sst.dk/da/udgivelser/2018/danskernes-sundhed-den-nationale-sundhedsprofil-2017. Accessed: January 22, 2019.
- Macleod LC, Hotaling JM, Wright JL, et al. Risk factors for renal cell carcinoma in the VITAL study. J Urol. 2013;190:1657–1661.
- Behrens G, Leitzmann MF. The association between physical activity and renal cancer: systematic review and meta-analysis. Br J Cancer. 2013;108:798–811.
- Cumberbatch MG, Rota M, Catto JW, et al. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol. 2016;70:458–466.
- Tan HJ, Chamie K, Daskivich TJ, et al. Patient function, long-term survival, and use of surgery in patients with kidney cancer. Cancer. 2016;122:3776–3784.
- Beisland C, Johannesen TB, Reisaeter LAR, et al. Real-life use of diagnostic biopsies before treatment of kidney cancer: results from a Norwegian population-based study. Scand J Urol. 2018;52:38–44.
- Brassart E, Lebdai S, Berger J, et al. Overall mortality after radical nephrectomy in patients aged over 80 years with renal cancer: a retrospective study on preoperative prognostic factors. Int J Urol. 2012;19:626–632.
- Larcher A, Trudeau V, Dell'Oglio P, et al. Prediction of competing mortality for decision-making between surgery or observation in elderly patients with T1 kidney cancer. Urology. 2017;102:130–137.
- Møller B, Fekjaer H, Hakulinen T, et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Statist Med. 2003;22:2751–2766.